Background:Pharmacological magnetic resonance imaging has been used to investigate the neural effects of subanaesthetic ketamine in healthy volunteers. However, the effect of ketamine has been modelled with a single time course and without consideration of physiological noise.Aims:This study aimed to investigate ketamine-induced alterations in resting neural activity using conventional pharmacological magnetic resonance imaging analysis techniques with physiological noise correction, and a novel analysis utilising simultaneously recorded electroencephalography data.Methods:Simultaneous electroencephalography/functional magnetic resonance imaging and physiological data were collected from 30 healthy male participants before and during a suba...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Aims: Pharmacological-challenge magnetic resonance imaging (phMRI) is powerful new tool enabling res...
The pharmacological modulation of functional connectivity in the brain may under-lie therapeutic eff...
Background: Subanesthetic dosages of the NMDAR antagonist, S-Ketamine, can cause changes in behavior...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Background: Behavioral and electrophysiological human ketamine models of schizophrenia are used for ...
Background: Anatomic sites within the brain, which activate in response to noxious stimuli, can be i...
Behavioral and electrophysiological human ketamine models of schizophrenia are used for testing comp...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Reliable measures of cognitive brain activity from functional neuroimaging techniques may provide ea...
Supplemental material, JOP822263_supplemental_material for Temporal dynamics of the pharmacological ...
In resting-state functional connectivity experiments, a steady state (of consciousness) is commonly ...
Quantifying neural activity in natural conditions (i.e. conditions comparable to the standard clinic...
Ketamine is a commonly used anesthetic; however, when administered at low-dose subanesthetic levels,...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Aims: Pharmacological-challenge magnetic resonance imaging (phMRI) is powerful new tool enabling res...
The pharmacological modulation of functional connectivity in the brain may under-lie therapeutic eff...
Background: Subanesthetic dosages of the NMDAR antagonist, S-Ketamine, can cause changes in behavior...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Background: Behavioral and electrophysiological human ketamine models of schizophrenia are used for ...
Background: Anatomic sites within the brain, which activate in response to noxious stimuli, can be i...
Behavioral and electrophysiological human ketamine models of schizophrenia are used for testing comp...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Reliable measures of cognitive brain activity from functional neuroimaging techniques may provide ea...
Supplemental material, JOP822263_supplemental_material for Temporal dynamics of the pharmacological ...
In resting-state functional connectivity experiments, a steady state (of consciousness) is commonly ...
Quantifying neural activity in natural conditions (i.e. conditions comparable to the standard clinic...
Ketamine is a commonly used anesthetic; however, when administered at low-dose subanesthetic levels,...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Aims: Pharmacological-challenge magnetic resonance imaging (phMRI) is powerful new tool enabling res...
The pharmacological modulation of functional connectivity in the brain may under-lie therapeutic eff...